Prenetics Acquires Act Genomics, Creating A Leader In Comprehensive Cancer Genetics And Precision Oncology
Acquiring Company
Prenetics
Acquired Company
ACT Genomics
Description
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that it is acquiring a majority stake in ACT Genomics Holdings Company Limited (“ACT”), an Asia based genomics company specializing in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and in the UK.
Quick answer
Prenetics is acquiring ACT Genomics, announced December 16, 2022.
- How much did Prenetics pay for ACT Genomics?
- The deal value was not disclosed.
- What does Prenetics do?
- Founded in 2014, Prenetics is a major global diagnostic and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars —..
Source: Fundz verified event record.
Other recent acquisitions in Medical and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bayer Acquires Blackford Analysis Ltd. Bolstering The Company’S Position In Digital Medical Imaging (January 18, 2023)
- Cultivate(Md) Capital Funds Announces Portfolio Company Embody'S Acquisition By Zimmer Biomet Holdings, Inc. (January 10, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Boston Scientific Announces Strategic Investment To Acquire Majority Stake Of Acotec Scientific Holdings Limited (December 11, 2022)
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
Who to call at Prenetics, and when
When Prenetics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Prenetics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prenetics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prenetics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prenetics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired ACT Genomics?
ACT Genomics was acquired by Prenetics. The deal was reported on December 16, 2022. Prenetics is publicly traded (PRE) and operates in Biotechnology.
When did Prenetics acquire ACT Genomics?
Prenetics's acquisition of ACT Genomics was reported on December 16, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ACT Genomics do?
ACT Genomics is an innovation-driven cancer solution provider with offices in Taipei, Hong Kong, Singapore, Tokyo, Bangkok and UK. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.